Real-time enrollment status for this geographic atrophy secondary to age-related macular degeneration clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 8:14 PM UTC
| NCT Number | NCT06765980 |
| Recruiting Status | Recruiting |
| Condition | Geographic Atrophy Secondary to Age-related Macular Degeneration |
| Phase | PHASE1 |
| Target Enrollment | 62 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Kriya Therapeutics, Inc. |
| Last Updated on CT.gov | August 10, 2026 (3 weeks ago) |
As of September 1, 2026: Clinical trial NCT06765980 is currently recruiting participants. This phase1 study for geographic atrophy secondary to age-related macular degeneration is actively seeking new participants at 1 location across the United States. The study is sponsored by Kriya Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06765980 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06765980 was last updated 3 weeks ago (August 10, 2026). HelloStudys verifies this status automatically.